HIPEC Improves Survival in Advanced Ovarian Cancer
Adding hyperthermic intraperitoneal chemotherapy to interval cytoreductive surgery improved relapse-free survival and overall survival for women with newly diagnosed stage III epithelial ovarian cancer.
Source: OncLive